Search results
Philip Broadley. Independent Non-Executive Director. Philip was appointed to the Board in July 2016, and served as Senior Independent Director from 31 March 2021 to 21 September 2023. He has extensive insurance experience having spent over 14 years in senior roles in insurance.
- Mission
- Governance
- Leadership
Our leadership, which includes our Board of Directors and Senior Executive Team, is accountable to our shareholders for the responsible conduct of the business and our long-term success. It also represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Our Directors are collectively responsible for the success of AstraZeneca. In addition, the Non-Executive Directors are responsible for exercising independent and objective judgement and for scrutinising and challenging management. The Board is responsible for setting our strategy and policies, oversight of risk and corporate governance and monitor...
In addition to the Board of Directors, our Senior Executive Team, or SET, is the body through which our Chief Executive Officer (CEO) exercises the authority delegated to him by the Board. Our CEO leads the SET and has executive responsibility for the management, development and performance of the business. The Chief Executive Officer, Chief Financ...
Philip Broadley has been Group Finance Director since November 2008. He is also a member of the Board Risk Committee and a non-executive director of Old Mutual (US) Holdings Inc, the parent ...
Dec 17, 2020 · Philip John Broadley Is The Independent Non-Executive Director of AstraZeneca PLC (LON:AZN) And They Just Picked Up 23% More Shares. Simply Wall St. Thu, Dec 17, 2020, 3:04 PM 3 min read.
Jul 29, 2022 · AstraZeneca PLC today announced the appointment of Michel Demaré as the Chair-designate of the Board. His appointment followed a robust succession planning process led by Philip Broadley in his capacity as senior independent Non-Executive Director. As previously communicated, Leif Johansson, current Chair of the Board of AstraZeneca will be ...
Nov 10, 2023 · Philip Broadley has been appointed non-executive director of Bermudian-based reinsurer Lancashire Holdings and will be the next chairman immediately after Lancashire’s 2024 annual meeting in May ...
In conversation with Philip Broadley of AstraZeneca. The pandemic forced many organisations to adapt at pace and this was certainly the case for those at the heart of developing and producing a viable vaccine. Over the past 18 months the pioneering work of AstraZeneca has thrust them into the spotlight and they suddenly became front page news.
